A couple weeks ago, I highlighted a Rosenbaum article in NEJM on "Metric Myopia" (do metrics pull attention to a few things while other issues go unattended). Blog here.
Let me quickly tie three articles together, from the last couple weeks.
- In NEJM April 20, Lisa Rosenbaum writes, "Metric Myopia - Trading Away our Clinical Judgement." Here.
- Pair that this week with an NEJM April 28 article, also by Lisa Rosenbaum, "Reassessing Quality Assessment - A Flawed System for Fixing a Flawed System." Here.
- And I'd make this a triple play, yet again in NEJM, by adding in Elizabeth Rourke's April 7 article, "Ten Years of Choosing Wisely to Reduce Low-Value Care," which in part argues that nominated topics are too often figureheads that are either low cost or rare or practiced by somebody else. Here.
Regarding "Reassessing Quality Assessment," see complaints by major organizations like IDSA (Infectious Disease Society of America) that review of a quality measure, SEP1 or NQF-500, was poorly handled by NQF - here. Coverage also at MedPageToday, here
Regarding the Rosenbaum series, see part 3 also, "Peers and Professionalism," here.
